Opening General Session: What’s New in Neonatology and Where Are We Headed? (GSI)

Monday, September 13, 2021

11:00 AM – 12:30 PM CDT

CE: 1

NCC Codes:
RNC-NIC: 4
NNP-BC: 5
RNC-LRN: 5
Pharmacology Credits: .75

Keynote Speaker(s)

Michael R. Narvey, MD, FRCPC, FAAP

Section Head, Neonatology; ; Medical Director of the Child Health Transport Team
Health Sciences Centre, Winnipeg, Manitoba, Manitoba, Canada

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Slides Handouts

Moderator(s)

RB

Rebecca Buchholtz, MSN, NNP-BC, APNP

Neonatal Nurse Practitioner
Children's Wisconsin

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Michael R. Narvey, MD, FRCPC, FAAP: Disclosure information not submitted.

Rebecca Buchholtz, MSN, NNP-BC, APNP : Disclosure information not submitted.

Dr. Narvey is a neonatologist and social media provider of medical information in the field of Neonatology. He will walk NANN attendees through current and exciting practices in the field and then look into the future to see what’s on the horizon. Prepare yourself for some controversial topics such as the artificial placenta, simulated amniotic fluid incubators, and stem cell therapy for BPD. Dr. Narvey will provide clarity on these topics and others as he examines the evidence out there so far.

Learning Objectives:

At the conclusion of this presentation, the learner will be able to:

Understand the changing landscape of surfactant administration
Discover how prophylactic hydrocortisone may change important outcomes in NICU
Understand how gestating outside the womb may soon become a reality